Article thumbnail

Treatment of autoimmune disease with extracorporeal photochemotherapy: progressive systemic sclerosis.

By A. H. Rook, B. Freundlich, G. T. Nahass, R. Washko, B. Macelis, M. Skolnicki, P. Bromley, W. K. Witmer and B. V. Jegasothy

Abstract

In this report, we describe the use of extracorporeal photochemotherapy in n the treatment of two patients with rapidly advancing progressive systemic sclerosis. Both patients experienced improvement in the cutaneous as well as the systemic manifestations of their disease while undergoing therapy. The potential therapeutic mechanisms are discussed

Topics: Research Article
Publisher: Yale Journal of Biology and Medicine
OAI identifier: oai:pubmedcentral.nih.gov:2589144
Provided by: PubMed Central

Suggested articles

Citations

  1. (1989). Inhibition ofantiskin allograft immunity by infusions with syngeneic photoinactivated effector lymphocytes.
  2. IR: Specific vaccination against photoinactivated cloned T cells.
  3. (1987). LaRoche L: Treatment of cutaneous T cell lymphoma by extracorporeal photochemotherapy: Preliminary results.
  4. (1986). Regulation ofautoimmune disease: Physiological and therapeutic. Immunol Rev 94:5,
  5. (1984). Rodnan GP: Lymphocytes in the skin of patients with progressive systemic sclerosis. Arthritis Rheum 27:645-653,
  6. (1986). SA: Inhibition of excessive scleroderma fibroblast collagen production by recombinant gamma-interferon. Arthritis Rheum 29:851-856,
  7. (1987). SA: Phenotype of peripheral blood lymphocytes in patients with progressive systemic sclerosis: Activated T lymphocytes and the effect ofpenicillamine therapy. Clin Exp Immunol 9:375-384,

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.